核子醫學分子造影於基因治療之應用

Translated title of the contribution: Non-Invasive Mapping of Gene Expression for Gene Therapy with Molecular Nuclear Medicine Imaging

鄧 文炳(Win-Ping Deng), Chih-Hsien Chang, 賴 文福(Wen-Fu Lai), Hsin-Ell Wang, Gann Ting, Wen K. Yang, Ren-Shyan Liu

Research output: Contribution to journalArticle

Abstract

The increasing knowledge of the molecular biology and molecular genetics of human diseases, particularly in human cancer, has led to the application of new biological therapeutic approaches such as gene-based therapy. A limitation of many gene-based therapies has been the inability to achieve controlled and effective delivery of gene to the target cells or tissues. In addition, several issues that are important for clinical optimization of gene therapy remain unresolved: (a) whether gene transduction has been successful; (b) what is the distribution of transduced target cells; (c) whether the level of gene expression is adequate. A noninvasive, clinically applicable method for imaging gene transduction in target tissue or specific organs of the body, thus assessing the kinetic changes of functional expression of the therapeutic gene, would be of considerable value. This paper reviewed and discussed the successful clinical application of this method to monitor gene expression which will require the appropriate combination of marker gene and marker substrate. This will facilitate the monitoring and evaluation of gene therapy in human subjects by defining the location, magnitude, and persistence of gene expression over time.
Original languageTraditional Chinese
Pages (from-to)237-246
Number of pages10
Journal核子醫學雜誌
Volume14
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Molecular Medicine
Nuclear Medicine
Genetic Therapy
Gene Expression
Genes
Molecular Biology
Inborn Genetic Diseases
Therapeutics
Neoplasms

Keywords

  • non-invasive
  • nuclear medicine imaging
  • cancer therapy
  • gene therapy
  • PET
  • SPECT
  • herpes simplex virus
  • thymidine kinase
  • marker substrate
  • marker gene
  • reporter gene

Cite this

鄧文炳(Win-Ping D, Chang, C-H., 賴文福(Wen-Fu L, Wang, H-E., Ting, G., Yang, W. K., & Liu, R-S. (2001). 核子醫學分子造影於基因治療之應用. 核子醫學雜誌, 14(4), 237-246. https://doi.org/10.6332/ANMS.1404.012

核子醫學分子造影於基因治療之應用. / 鄧文炳(Win-Ping Deng); Chang, Chih-Hsien; 賴文福(Wen-Fu Lai); Wang, Hsin-Ell; Ting, Gann; Yang, Wen K. ; Liu, Ren-Shyan.

In: 核子醫學雜誌, Vol. 14, No. 4, 2001, p. 237-246.

Research output: Contribution to journalArticle

鄧文炳(Win-PingD, Chang, C-H, 賴文福(Wen-FuL, Wang, H-E, Ting, G, Yang, WK & Liu, R-S 2001, '核子醫學分子造影於基因治療之應用', 核子醫學雜誌, vol. 14, no. 4, pp. 237-246. https://doi.org/10.6332/ANMS.1404.012
鄧文炳(Win-PingD, Chang C-H, 賴文福(Wen-FuL, Wang H-E, Ting G, Yang WK et al. 核子醫學分子造影於基因治療之應用. 核子醫學雜誌. 2001;14(4):237-246. https://doi.org/10.6332/ANMS.1404.012
鄧文炳(Win-Ping Deng) ; Chang, Chih-Hsien ; 賴文福(Wen-Fu Lai) ; Wang, Hsin-Ell ; Ting, Gann ; Yang, Wen K. ; Liu, Ren-Shyan. / 核子醫學分子造影於基因治療之應用. In: 核子醫學雜誌. 2001 ; Vol. 14, No. 4. pp. 237-246.
@article{ac7759dbdc05400da81ab89c748c9a7d,
title = "核子醫學分子造影於基因治療之應用",
abstract = "分子生物及分子遺傳技術突飛猛進,對於人類的疾病,特別是惡性腫瘤「癌症」希望能找出有效的治療方式,基因治療便是其中之一。惡性腫瘤的基因治療在臨床應用前,下列幾個問題必須獲得解答:基因在體內是否轉植成功?是否表現?是否表現在標的器官(target organ)或標的組織(target tissue)?表現是否適量?何時會表現到最大量?何時是治療用藥最合適的時刻?表現時間多長?是否達到治療效果?理論上,非侵入性核醫分子造影可以回答以上的各項問題,其方法是在植入基因中加入一段「指標基因(marker gene)」,再配合使用其相對的「指標受質(marker substrate)」,藉由非侵入性核醫分子造影,在不同時間監測含有放射性同位素標幟之「指標受質」在體內分佈與代謝;如此,藉由動力學的測量(kinetic measurements),可以分析轉植基因在體內表現最為適當的時間、數量及生物分佈,同時病人不需接受侵入性組織切片檢查之痛苦與風險。本文回顧全世界運用核醫分子造影,並追蹤基因產物在體內表現的時間及數量,以確認基因治療效果等有關研究之現況與未來之展望。",
keywords = "非侵入性, 核子醫學造影, 癌症治療, 基因治療, 正子電腦斷層掃描, 單光子電腦斷層掃描, non-invasive, nuclear medicine imaging, cancer therapy, gene therapy, PET, SPECT, herpes simplex virus, thymidine kinase, marker substrate, marker gene, reporter gene",
author = "鄧, {文炳(Win-Ping Deng)} and Chih-Hsien Chang and 賴, {文福(Wen-Fu Lai)} and Hsin-Ell Wang and Gann Ting and Yang, {Wen K.} and Ren-Shyan Liu",
year = "2001",
doi = "10.6332/ANMS.1404.012",
language = "繁體中文",
volume = "14",
pages = "237--246",
journal = "核子醫學雜誌",
issn = "1022-923X",
publisher = "中華民國核子醫學學會",
number = "4",

}

TY - JOUR

T1 - 核子醫學分子造影於基因治療之應用

AU - 鄧, 文炳(Win-Ping Deng)

AU - Chang, Chih-Hsien

AU - 賴, 文福(Wen-Fu Lai)

AU - Wang, Hsin-Ell

AU - Ting, Gann

AU - Yang, Wen K.

AU - Liu, Ren-Shyan

PY - 2001

Y1 - 2001

N2 - 分子生物及分子遺傳技術突飛猛進,對於人類的疾病,特別是惡性腫瘤「癌症」希望能找出有效的治療方式,基因治療便是其中之一。惡性腫瘤的基因治療在臨床應用前,下列幾個問題必須獲得解答:基因在體內是否轉植成功?是否表現?是否表現在標的器官(target organ)或標的組織(target tissue)?表現是否適量?何時會表現到最大量?何時是治療用藥最合適的時刻?表現時間多長?是否達到治療效果?理論上,非侵入性核醫分子造影可以回答以上的各項問題,其方法是在植入基因中加入一段「指標基因(marker gene)」,再配合使用其相對的「指標受質(marker substrate)」,藉由非侵入性核醫分子造影,在不同時間監測含有放射性同位素標幟之「指標受質」在體內分佈與代謝;如此,藉由動力學的測量(kinetic measurements),可以分析轉植基因在體內表現最為適當的時間、數量及生物分佈,同時病人不需接受侵入性組織切片檢查之痛苦與風險。本文回顧全世界運用核醫分子造影,並追蹤基因產物在體內表現的時間及數量,以確認基因治療效果等有關研究之現況與未來之展望。

AB - 分子生物及分子遺傳技術突飛猛進,對於人類的疾病,特別是惡性腫瘤「癌症」希望能找出有效的治療方式,基因治療便是其中之一。惡性腫瘤的基因治療在臨床應用前,下列幾個問題必須獲得解答:基因在體內是否轉植成功?是否表現?是否表現在標的器官(target organ)或標的組織(target tissue)?表現是否適量?何時會表現到最大量?何時是治療用藥最合適的時刻?表現時間多長?是否達到治療效果?理論上,非侵入性核醫分子造影可以回答以上的各項問題,其方法是在植入基因中加入一段「指標基因(marker gene)」,再配合使用其相對的「指標受質(marker substrate)」,藉由非侵入性核醫分子造影,在不同時間監測含有放射性同位素標幟之「指標受質」在體內分佈與代謝;如此,藉由動力學的測量(kinetic measurements),可以分析轉植基因在體內表現最為適當的時間、數量及生物分佈,同時病人不需接受侵入性組織切片檢查之痛苦與風險。本文回顧全世界運用核醫分子造影,並追蹤基因產物在體內表現的時間及數量,以確認基因治療效果等有關研究之現況與未來之展望。

KW - 非侵入性

KW - 核子醫學造影

KW - 癌症治療

KW - 基因治療

KW - 正子電腦斷層掃描

KW - 單光子電腦斷層掃描

KW - non-invasive

KW - nuclear medicine imaging

KW - cancer therapy

KW - gene therapy

KW - PET

KW - SPECT

KW - herpes simplex virus

KW - thymidine kinase

KW - marker substrate

KW - marker gene

KW - reporter gene

U2 - 10.6332/ANMS.1404.012

DO - 10.6332/ANMS.1404.012

M3 - 文章

VL - 14

SP - 237

EP - 246

JO - 核子醫學雜誌

JF - 核子醫學雜誌

SN - 1022-923X

IS - 4

ER -